home / stock / xlo / xlo articles

XLO Articles, Xilio Therapeutics Inc.

Stock Information
Company Name: Xilio Therapeutics Inc.
Stock Symbol: XLO
Market: NASDAQ
Menu
XLO XLO Quote XLO Short XLO News XLO Articles XLO Message Board
Get XLO Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quar...
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG...

Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results | Benzinga

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow traded up 0.06% to 39,7...

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth...
Cancer Focused Micro-Cap Xilio Therapeutics Stock Doubles In One Session - Here's Why | Benzinga

Xilio Therapeutics Inc (NASDAQ:XLO) shares are surging as the company announced an exclusive license agreement with Gilead Sciences Inc&n...

Gold Gains 1%; Walgreens Narrows Earnings Forecast | Benzinga

U.S. stocks traded slightly higher midway through trading, with the S&P 500 gaining around 0.1% on Thursday. The Dow traded up 0.06% to 39,785....

US Stocks Flat; Initial Jobless Claims Fall To 210,000 | Benzinga

U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday. Following the market opening Thursday, the Dow tra...
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing | Benzinga

Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and X...

Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference | Benzinga

WALTHAM, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and ...

Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference | Benzinga

WALTHAM, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and ...
Next 10